Coronavirus Latest News

US Food and Drug Administration struggles to remain independent amid race for coronavirus cure

This story is published in a content partnership with POLITICO. It was originally reported by Sarah Owermohle on politico.com on June 3, 2020Peter Marks was a natural fit for a new White House project tasked with developing a coronavirus vaccine. The cancer specialist spent nearly a decade at the Food and Drug Administration, most recently overseeing the office that approves vaccines and gene therapies.But Marks quit last month just days after joining US President Donald Trump’s Operation Warp…

Read the original article at South China Morning Post

Related Articles

Back to top button